Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
17.83
-0.80 (-4.29%)
Oct 13, 2026, 4:00 PM EDT - Market closed
Apnimed Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Apnimed stock has a consensus rating of "Strong Buy" and an average price target of $50.33. The average 1-year stock price forecast is 182.28% higher than the current stock price, while the lowest is $41 (+129.95%) and the highest is $60 (+236.51%).
Price Target: $50.33 (+182.28%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Apnimed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $41 | Buy | Maintains | $41 | +129.95% | Oct 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $50 | Buy | Maintains | $50 | +180.43% | Sep 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $60 | Buy | Initiates | $60 | +236.51% | Aug 25, 2026 |
| Evercore ISI | Evercore ISI | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 25, 2026 |
Financial Forecast
Revenue This Year
90.85M
from 38.47M
Increased by 136.17%
Revenue Next Year
22.44M
from 90.85M
Decreased by -75.30%
EPS This Year
-0.06
EPS Next Year
-3.98
from -0.06
EPS and Forward PE are based on non-GAAP adjusted numbers.